Rocket Pharmaceuticals, Inc. (RCKT) short interest & options flow
NASDAQRocket Pharmaceuticals heads into its May 11 earnings release carrying one of the heavier short burdens in the small-cap biotech space — and bears built most of that position in the last month alone. Short interest is the defining feature of the current setup. At roughly 17.9% of the free float, the short position is substantial for a stock trading at $3.67. More striking is the…
- Market cap
- $272M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026

RCKT news and analysis
RSSNo long-form analysis yet for RCKT. Pulse alerts and the live data picture are available on ORTEX.
Open RCKT on ORTEX →Want the live picture for RCKT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RCKT — free to start on ORTEX.
Sign up for free →Open RCKT on ORTEX